A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation

被引:3
作者
Endo, T
Sato, N
Koizumi, K
Nishio, M
Fujimoto, K
Yamamoto, S
Sakai, T
Bohgaki, T
Sawada, K
Koike, T
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Hosp Med, Blood Transfus Serv, Sapporo, Hokkaido, Japan
[3] Akita Univ, Sch Med, Dept Internal Med 3, Akita 010, Japan
关键词
autologous PBSC transplantation; CD34; positive selection; Th1; Th2;
D O I
10.1080/14653240410004907
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background CD34(+) cell-selected autologous PBSC transplantation (CD34(+) APBSCT) is a procedure used for the treatment of patients with malignant disease that is intended to eliminate residual tumor cells from autologous grafts. However, frequent infectious complications after CD34(+) APBSCT can occur. A delay of recovery of the absolute number of CD4(+) T cells after transplantation was reported to be one disadvantageous factor. As data on T-cell function after CD34(+) APBSCT are scanty, we analyzed changes in T-helper cell 1 (Th1) and T-helper cell 2 (Th2) after CD34(+) APBSCT to evaluate immune reconstitution. Methods Twelve patients underwent APBSCT (CD34(+) APBSCT group, n = 4, and unselected APBSCT, n = 8). Peripheral blood (PB) samples were obtained at 2, 4, 8, 12 and 16 weeks after the transplantation. The dynamics of the Th1 and Th2 were analyzed at a single-cell level, using flow cytometry. Results In the CD34(+) APBSCT group, not only the absolute count of CD4(+) T cells but also the proportion of Th1 cells in CD4(+) T cells and the ratio of Th1 to Th2 after transplantation were significantly decreased at 2 and 4 weeks after transplantation compared with findings in the unselected APBSCT group. Discussion We suggest that higher rates of infectious complications after CD34(+) APBSCT may be due to the inability of residual T cells from the CD34(+) cell selection to generate mature T cells that function adequately against infection. Although further study would be required, our preliminary data provide some information on the immune reconstitution after CD34(+) APBSCT and differentiation of T lymphocytes into Th1 and Th2 in vivo.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 33 条
[1]   Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma [J].
Abonour, R ;
Scott, KM ;
Kunkel, LA ;
Robertson, MJ ;
Hromas, R ;
Graves, V ;
Lazaridis, EN ;
Cripe, L ;
Gharpure, V ;
Traycoff, CM ;
Mills, B ;
Srour, EF ;
Cornetta, K .
BONE MARROW TRANSPLANTATION, 1998, 22 (10) :957-963
[2]   SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOLLOWING STANDARD-DOSE COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN [J].
BRUGGER, W ;
FRISCH, J ;
SCHULZ, G ;
PRESSLER, K ;
MERTELSMANN, R ;
KANZ, L .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) :1452-1459
[3]   Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation - Relationship with the occurrence of acute graft-versus-host disease [J].
Carayol, G ;
Bourhis, JH ;
Guillard, M ;
Bosq, J ;
Pailler, C ;
Castagna, L ;
Vernant, JP ;
Pico, JL ;
Hayat, M ;
Chouaib, S ;
Caignard, A .
TRANSPLANTATION, 1997, 63 (09) :1307-1313
[4]  
Essa S, 2000, J MED VIROL, V60, P223, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt
[5]  
223::AID-JMV19&gt
[6]  
3.0.CO
[7]  
2-W
[8]   Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation [J].
Friedman, J ;
Lazarus, HM ;
Koç, ON .
BONE MARROW TRANSPLANTATION, 2000, 26 (08) :831-836
[9]   Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation [J].
Holmberg, LA ;
Boeckh, M ;
Hooper, H ;
Leisenring, W ;
Rowley, S ;
Heimfeld, S ;
Press, O ;
Maloney, DG ;
McSweeney, P ;
Corey, L ;
Maziarz, RT ;
Appelbaum, FR ;
Bensinger, W .
BLOOD, 1999, 94 (12) :4029-4035
[10]   Large scale purification of human blood CD34+ cells using a nylon-fiber syringe system and immunomagnetic microspheres [J].
Koizumi, K ;
Sawada, K ;
Sato, N ;
Yamaguchi, M ;
Nishio, M ;
Tarumi, T ;
Takano, H ;
Fukada, Y ;
Ieko, M ;
Yasukouchi, T ;
Sekiguchi, S ;
Koike, T .
CYTOTHERAPY, 1999, 1 (04) :319-327